Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats

Diabetes

Volumn 57, Issue 3, 2008, Pages 614-622

  Shapiro, Alexandra ^a   Matheny, Michael ^a   Zhang, Yi ^a,b   Turner, Nihal ^a,b   Cheng, Kit Yan ^a   Rogrigues, Enda ^a   Zolotukhin, Sergei ^a   Scarpace, Philip J ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; GREEN FLUORESCENT PROTEIN; HORMONE SENSITIVE LIPASE; LEPTIN; PARVOVIRUS VECTOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; 11BETA HYDROXYSTEROID DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RUNNING; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT GAIN; ADIPOSE TISSUE; ANIMAL; BLOOD; CHEMISTRY; DIET; EATING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ANIMALS; CORTICOSTERONE; DIET; EATING; GENE EXPRESSION REGULATION; GENE THERAPY; LEPTIN; MALE; MOTOR ACTIVITY; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 40949104015     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0863     Document Type: Article

References (35)

1. Ahima RS, Flier JS: Leptin. Anna, Rev Physiol 62:413-437, 2000
2. Scarpace PJ, Matheny M, Zhang Y, Tumer N, Frase CD, Shek EW, Hong B, Prima V, Zolotukhin S: Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats. Neuropharmacology 42:548-561, 2002
3. Wilsey J, Zolotukhin S, Prima V, Scarpace PJ: Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am J Physiol Regal Integr Comp Physiol 285:R1011-R1020, 2003
4. Scarpace PJ, Matheny M, Tumer N, Cheng KY, Zhang Y: Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats. Diabetologia 48:1075-1083, 2005
5. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314, 1995
6. Widdowson PS, Upton R, Buckingham R, Arch J, Williams G: Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes 46:1782-1785, 1997
7. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad, Sci USA 94:8878-8883, 1997
8. Slentz CA, Duscha BD, Johnson JL, Ketchum K, Aiken LB, Samsa GP, Houmard JA, Bales CW, Kraus WE: Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE: a randomized controlled study. Arch Intern Med 164:31-39, 2004
9. Flores MB, Fernandes MF, Ropelle ER, Faria MC, Ueno M, Velloso LA, Saad MJ, Carvalheira JB: Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 55:2554-2561, 2006
10. Levin BE, Dunn-Meynell AA: Chronic exercise lowers the defended body weight gain and adiposity in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 286:R771-R778, 2004
11. Scarpace PJ, Matheny M, Zhang Y, Shek EW, Prima V, Zolotukhin S, Tumer N: Leptin-induced leptin resistance reveals separate roles for the anorexic and thermogenic responses in weight maintenance. Endocrinology 143: 3026-3035, 2002
12. Berger I, Fitzgerald DJ, Richmond TJ: Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22:1583-1587, 2004
13. Urabe M, Nakakura T, Xin KQ, Obara Y, Mizukami H, Kume A, Kotin RM, Ozawa K: Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J Virol 80:1874-1885, 2006
14. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N: Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973-985, 1999
15. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ, Jr, Chiodo VA, Phillipsberg T, Muzyczka N, Hauswirth WW, Flotte TR, Byrne BJ, Snyder RO: Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28:158-167, 2002
16. Scarpace PJ, Matheny M, Tumer N: Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 104:1111-1117, 2001
17. Unger RH: Leptin physiology: a second look. Regul Pept 92:87-95, 2000
18. Wake DJ, Walker BR: Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity. Endocrine 29:101-108, 2006
19. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS: Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1:445-450, 1998
20. Scarpace PJ, Matheny M, Zolotukhin S, Tumer N, Zhang Y: Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II. Neuropharmacology 45:211-219, 2003
21. Scarpace PJ, Matheny M, Moore RL, Tumer N: Impaired leptin responsiveness in aged rats. Diabetes 49:431-435, 2000
22. Scarpace PJ, Matheny M, Shek EW: Impaired leptin signal transduction with age-related obesity. Neuropharmacology 39:1872-1879, 2000
23. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832, 2000
24. Martin RL, Perez E, He YJ, Dawson R Jr, Millard WJ: Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein down- regulation. Metabolism 49:1479-1484, 2000
25. Wilsey J, Scarpaee PJ: Caloric restriction reverses the deficits in leptin receptor protein and leptin signaling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J Endocrinol 181:297-306, 2004
26. Wilsey J, Matheny MK, Scarpace PJ: Oral vanadium enhances the catabolie effects of central leptin in young adult rats. Endocrinology 147:493-501, 2006
27. Krebs DL, Hilton DJ: SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378-387, 2001
28. Wisse BE, Ogimoto K, Morton GJ, Williams DL, Schwartz MW: Central interleukin-1 (IL1) signaling is required for pharmacological, but not physiological, effects of leptin on energy balance. Brain Res 1144:101-106, 2007
29. Nonogaki K: New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533-549, 2000
30. Carmen GY, Victor SM: Signalling mechanisms regulating lipolysis. Cell Signal 18:401-408, 2006
31. Mark AL, Correia ML, Rahmouni K, Haynes WG: Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20:1245-1250, 2002
32. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS: Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90, 2003
33. MasuzaM H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170, 2001
34. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR: Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938, 2004
35. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ: 11beta-hydroxy- steroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:14924-14929, 1997